Hospital admissions for Guillain-Barré syndrome in the United States, 1993-2004
- PMID: 17925599
- DOI: 10.1159/000109501
Hospital admissions for Guillain-Barré syndrome in the United States, 1993-2004
Abstract
Background: The hospitalization rate for Guillain-Barré syndrome (GBS) in the USA has recently decreased. This study examined which demographic groups were affected and whether there were any changes in medical care that might explain the decrease.
Methods: Information about hospitalizations for GBS was obtained from the 1993-2004 annual Nationwide Inpatient Sample and used to estimate hospitalization rates and the medical characteristics of hospitalized GBS patients.
Results: The GBS hospitalization rate decreased 20.1% (95% CI 18.3-21.9%) between 1993 and 2004. Most groups were affected by the decrease except persons aged 18-44 years. There were several changes in medical care during the period, including a reduction in interhospital transfers and a shift from plasmapheresis to intravenous immunoglobulin (IVIg) therapy.
Conclusions: The reduction in transfers accounted for about one-fourth of the decrease in the GBS hospitalization rate, and may have been related to the shift from plasmapheresis to IVIg therapy. The other causes of the decrease are unknown.
(c) 2007 S. Karger AG, Basel.
Similar articles
-
Economic cost of Guillain-Barré syndrome in the United States.Neurology. 2008 Jul 1;71(1):21-7. doi: 10.1212/01.wnl.0000316393.54258.d1. Neurology. 2008. PMID: 18591502
-
Immunotherapy for Guillain-Barré syndrome in the US hospitals.J Clin Neuromuscul Dis. 2008 Sep;10(1):4-10. doi: 10.1097/CND.0b013e318182b5ce. J Clin Neuromuscul Dis. 2008. PMID: 18772694
-
Guillain-Barré syndrome: incidence and mortality rates in US hospitals.Neurology. 2008 Apr 29;70(18):1608-13. doi: 10.1212/01.wnl.0000310983.38724.d4. Neurology. 2008. PMID: 18443311
-
Guillain-Barré syndrome--a patient guide and nursing resource.Axone. 2001 Jun;22(4):16-24. Axone. 2001. PMID: 14621501 Review.
-
[Guillain-Barré syndrome in the northern area of Gran Canaria and the island of Lanzarote].Rev Neurol. 2002 Oct 16-31;35(8):705-10. Rev Neurol. 2002. PMID: 12402219 Review. Spanish.
Cited by
-
Post-Marketing Safety Surveillance for the Adjuvanted Recombinant Zoster Vaccine: Methodology.Drug Saf. 2020 Dec;43(12):1223-1234. doi: 10.1007/s40264-020-00989-2. Drug Saf. 2020. PMID: 32862397 Free PMC article.
-
An assessment of the human health impact of seven leading foodborne pathogens in the United States using disability adjusted life years.Epidemiol Infect. 2015 Oct;143(13):2795-804. doi: 10.1017/S0950268814003185. Epub 2015 Jan 30. Epidemiol Infect. 2015. PMID: 25633631 Free PMC article.
-
Direct Outpatient Health Care Costs Among Commercially Insured Persons for Common Foodborne Pathogens and Acute Gastroenteritis, 2012-2015.Foodborne Pathog Dis. 2022 Aug;19(8):558-568. doi: 10.1089/fpd.2021.0108. Foodborne Pathog Dis. 2022. PMID: 35960532 Free PMC article.
-
Inpatient management of guillain-barré syndrome.Neurohospitalist. 2011 Apr;1(2):78-84. doi: 10.1177/1941875210396379. Neurohospitalist. 2011. PMID: 23983841 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical